Skip to content

Effect of Nimba-Amalakyadi Choorna in Diabetes Mellitus

Evaluation of comparative efficacy of Nimba-Amalakyadi Choorna with that of Metformin in the management of Diabetes Mellitus Type II (Prameha)

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/08/036034
Enrollment
36
Registered
2021-08-31
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E08-E13- Diabetes mellitus

Interventions

None listed

Sponsors

Datta Meghe Institute of health sciences
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: • Patients with either sex having age between 20 -60 years • Patients recently diagnosed for uncomplicated NIDDM (type 2 diabetes) ( ï?¶ Fasting blood sugar level >100-125 mg/dl ï?¶ Post meal blood sugar level > 140- 300 mg/dl ï?¶ HbA1c level 5.7% - 8 % • Patients with and old cases of type-2 DM not taking any other anti-hypoglycaemic drugs. • Diabetic Patients suffering from Controlled Hypertension (Blood Pressure not more than >=140 mmHg or an average Diastolic Blood Pressure not more than >=90 mmHg) • Patients willing to give informed consent

Exclusion criteria

Exclusion criteria: • Patients suffering from IDDM (Insulin dependent diabetes mellitus) & patient with Type -2 Diabetes patients on insulin therapy • Patients suffering from Juvenile Diabetes or Gestational diabetes (ICD â?? 10 criteria 024) Impaired glucose tolerance (ICD- 10 criteria R73.0) • DM with complications e.g. Retinopathy, Nephropathy, neuropathy ,previous history of coma • Patients suffering from any current acute illness, uncontrolled hypertension

Design outcomes

Primary

MeasureTime frame
reductions in Fasting & post prandial Blood Sugar Levels & Hb A 1 c values of patients with diabetes mellitus type II Timepoint: after 3 months

Secondary

MeasureTime frame
Improvement in symptoms of Diabetes mellitus type IITimepoint: 45 days

Countries

India

Contacts

Public ContactDr Punam Sawarakar

Associate Professor

drsuple.punam@gmail.com9860667023

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026